Pharmaceutical News

RSS

LCA applauds FDA approval of Xalkori for ALK positive non-small cell lung cancer

Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive. The drug was approved based on data from two clinical trials, both of which showed a significant increase in overall survival.

2 Sep 2011

FDA may be allowed an extra 2 months to review new drugs

The deadline for approval or rejection of new drugs by the Food and Drug Administration (FDA) could be extended by two months say U.S. regulators and drug industry officials.

2 Sep 2011

Study reveals how pharmaceutical managers can maximize the return on marketing investments

Research in Marketing Science by Professor Kamel Jedidi, John A. Howard Professor of Business, Marketing, Columbia Business School; Professor Oded Netzer, Philip H. Geier Jr. Associate Professor, Marketing, Columbia Business School; and Professor Ricardo Montoya, Department of Industrial Engineering, University of Chile, Santiago, Chile, reveals how pharmaceutical managers can maximize the return on marketing investments - by determining the physicians to target as well as when and how to target them.

31 Aug 2011

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Selecta Biosciences, Inc., a biopharmaceutical company developing an entirely new class of targeted vaccines and immunotherapies, today announced that Science Applications International Corporation (SAIC) has awarded Selecta a subcontract to develop a targeted synthetic vaccine particle product for malaria.

31 Aug 2011

Research shows numerous health benefits of Modified Citrus Pectin

New research published in the journal BMC Complementary and Alternative Medicine shows Modified Citrus Pectin (MCP) packs a powerful immune punch.

31 Aug 2011

Comprehensive review on non-drug interventions for treatment of high blood pressure

More and more, patients show up to appointments with hypertension expert John Bisognano, M.D., Ph.D. carrying bags full of "natural" products that they hope will help lower their blood pressure. And like most physicians, Bisognano doesn't always know if these products will do any good, or if they will cause any harm.

31 Aug 2011

Cost of second-line ARVs a 'huge barrier to care' in resource-poor countries

In this U.N. Dispatch blog post, Mark Leon Goldberg, managing editor of the blog, examines the costs of second-line antiretroviral treatments (ARVs), which "are several orders of magnitude more expensive than traditional, first-line ARV treatments" and are a "huge barrier to providing care" for resource-poor countries.

31 Aug 2011

Insight Pharmaceuticals announces acquisition of MONISTAT business from McNEIL-PPC

Insight Pharmaceuticals, a portfolio company of Swander Pace Capital, announced today that it has acquired the MONISTAT North American brand portfolio from McNEIL-PPC, Inc.

31 Aug 2011

Perrigo's ANDA for Ketoconazole Foam, 2% receives final FDA approval to treat seborrheic dermatitis

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Ketoconazole Foam, 2%, the generic version of Extina Ketoconazole Foam, 2%.

31 Aug 2011

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.

30 Aug 2011

AAMPS, ChromaDex sign exclusive marketing agreement for African Herbal Pharmacopoeia

ChromaDex Corporation, a world leader in phytochemical reference standards, botanical reference materials and contract analytical testing services, has signed an exclusive marketing agreement with the Association for African Medicinal Plants Standards (AAMPS) to sell and market the AAMPS African botanical standards and the African Herbal Pharmacopoeia.

30 Aug 2011

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

Two scientists developed a new drug that helped pioneer the era of "personalized medicine" for cancer patients, an approach in which one-size-fits-all drugs yield to medicines customized to the genetic endowment of individual patients. Another scientist invented today's predominant technology for genetic sequencing, deciphering the genetic blueprint in the DNA that makes up the genes of living things.

30 Aug 2011

Vitamin A supplements could save the lives of 600,000 children a year, researchers say

"Giving vitamin A supplements to children under the age of five in developing countries could save 600,000 lives a year, researchers claim" in a paper published Thursday in the British Medical Journal, BBC News reports.

30 Aug 2011

AstraZeneca: BRILIQUE receives Class I recommendation from ESC

AstraZeneca today announced BRILIQUE, a new oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines for Management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation."

30 Aug 2011

Everolimus-eluting stent reduces incidence of stent thrombosis

Results of the independently-funded Bern-Rotterdam cohort study provide robust evidence of an "important" reduction in overall and very late stent thrombosis.

30 Aug 2011

Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe

Ipsen and Inspiration Biopharmaceuticals Inc. today announced they have entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration's hemophilia product portfolio in Europe.

30 Aug 2011

Vitamin C supplementation might benefit children with asthma

Depending on the age of asthmatic children, on their exposure to molds or dampness in their bedroom, and on the severity of their asthma, vitamin C has greater or smaller beneficial effect against asthma, according to a study published in the Clinical and Translational Allergy.

30 Aug 2011

High risk of serious complications or death in children with SP-HUS

Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.

30 Aug 2011

Study indicates large gap in use of proven therapies for heart attack or stroke

A global study in 17 countries led by McMaster University researchers has found too few patients are using drugs proven to give significant benefits in warding off a heart attack or stroke.

30 Aug 2011

Ivabradine reduces heart volume among patients with cardiac insufficiency

As guest speaker at the European Society of Cardiology's Congress currently under way in Paris, Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute's Research Centre and professor of medicine at the Universit- de Montr-al, today presented the results of an analysis demonstrating that ivabradine, a medication used to reduce heart rate, also reduces heart volume (left ventricle) among patients with cardiac insufficiency.

30 Aug 2011

Pharmaceutical News

LCA applauds FDA approval of Xalkori for ALK positive non-small cell lung cancer

FDA may be allowed an extra 2 months to review new drugs

Study reveals how pharmaceutical managers can maximize the return on marketing investments

SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria

Research shows numerous health benefits of Modified Citrus Pectin

Comprehensive review on non-drug interventions for treatment of high blood pressure

Cost of second-line ARVs a 'huge barrier to care' in resource-poor countries

Insight Pharmaceuticals announces acquisition of MONISTAT business from McNEIL-PPC

Perrigo's ANDA for Ketoconazole Foam, 2% receives final FDA approval to treat seborrheic dermatitis

FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation

AAMPS, ChromaDex sign exclusive marketing agreement for African Herbal Pharmacopoeia

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

Vitamin A supplements could save the lives of 600,000 children a year, researchers say

AstraZeneca: BRILIQUE receives Class I recommendation from ESC

Everolimus-eluting stent reduces incidence of stent thrombosis

Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe

Vitamin C supplementation might benefit children with asthma

High risk of serious complications or death in children with SP-HUS

Study indicates large gap in use of proven therapies for heart attack or stroke

Ivabradine reduces heart volume among patients with cardiac insufficiency

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News